Technical advances in lenses are continuous and materials are improved. We provide a prospective longitudinal observational study evaluating the efficacy and safety of new EyeBrid Excel hybrid lenses (LCS) in the treatment of severe ametropia and for patients with corneal irregularities. This study should include 60 patients for a period of three months. The aim of this work is to assess the improvement in the best corrected visual acuity and the good tolerance of this lens.
Study Type
OBSERVATIONAL
Enrollment
60
new lenses
Caen University Hospital
Caen, France
tolerance assesment
scale of discomfort when using contact lenses
Time frame: 3 month
Improvement of visual acuity
measurement of visual acuity by the ETDRS charts
Time frame: 3 month
Assessment and quantification of complications
note the number of abscesses
Time frame: 3 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.